Multiplexed biosensor for point-of-care COVID-19 monitoring: CRISPR-powered unamplified RNA diagnostics and protein-based therapeutic drug management

This article has been Reviewed by the following groups

Read the full article See related articles

Abstract

No abstract available

Article activity feed

  1. SciScore for 10.1101/2022.03.30.22271928: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Ethicsnot detected.
    Sex as a biological variablenot detected.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.

    Table 2: Resources

    Antibodies
    SentencesResources
    As the glucose oxidase (GOx)-conjugated (see Supporting Information) monoclonal anti-6-FAM antibody (SAB4600050-125UL, Merck, Germany) will now only bind to the 6-FAM label on the 5’ end of uncleaved reRNA, the signal obtained in the amperometric readout is highly specific and inversely proportional to the target concentration within the sample solution. β-lactam Detection: Functionalization of the immobilization area is accomplished by incubation with penicillin binding protein 3 (PBP-337; 250 µg ml−1 in PBS (10 mM; pH 7.4), expressed via in-house production) for 1 hour, followed by 30 minutes of blocking with biotin-free casein (85R-108, Fitzgerald, USA).
    anti-6-FAM
    suggested: None
    SAB4600050-125UL
    suggested: None
    penicillin binding protein 3
    suggested: None
    casein ( 85R-108
    suggested: None
    Software and Algorithms
    SentencesResources
    The protein concentration is determined by use of the Bradford method (Bio-Rad laboratories, USA) with bovine serum albumin (Carl Roth, Germany) as standard and the concentration of the pure protein is determined by analyzing the SDS gels with ImageJ.
    ImageJ
    suggested: (ImageJ, RRID:SCR_003070)
    Clinical Samples and RNA-Extraction: Patient samples were provided by the Medical Center – University of Freiburg and lysed in the Alinity Lysis Solution (09N20-001, Abbott, USA).
    Abbott
    suggested: (Abbott, RRID:SCR_010477)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.


    Results from JetFighter: We did not find any issues relating to colormaps.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    Results from scite Reference Check: We found no unreliable references.


    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.